These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 1306524

  • 21. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
    Persani L, Borgato S, Lania A, Filopanti M, Mantovani G, Conti M, Spada A.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813
    [Abstract] [Full Text] [Related]

  • 22. Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase.
    Spada A, Arosio M, Bochicchio D, Bazzoni N, Vallar L, Bassetti M, Faglia G.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1421-6. PubMed ID: 1977758
    [Abstract] [Full Text] [Related]

  • 23. Two G protein oncogenes in human endocrine tumors.
    Lyons J, Landis CA, Harsh G, Vallar L, Grünewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR.
    Science; 1990 Aug 10; 249(4969):655-9. PubMed ID: 2116665
    [Abstract] [Full Text] [Related]

  • 24. Mutations in the alpha subunit of the stimulatory regulatory protein of adenylyl cyclase (Gs) in human GH-secreting pituitary adenomas. Biochemical, clinical, and morphological aspects.
    Spada A, Arosio M, Bassetti M, Vallar L, Clementi E, Bazzoni N.
    Pathol Res Pract; 1991 Jun 10; 187(5):567-70. PubMed ID: 1923949
    [Abstract] [Full Text] [Related]

  • 25. [Guanidine nucleotide binding proteins as membrane signal transduction components and regulators of enzymatic effectors].
    Rosenthal W, Schultz G.
    Klin Wochenschr; 1988 Jun 15; 66(12):511-23. PubMed ID: 2843711
    [Abstract] [Full Text] [Related]

  • 26. Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis.
    Yoshimoto K, Iwahana H, Fukuda A, Sano T, Itakura M.
    Cancer; 1993 Aug 15; 72(4):1386-93. PubMed ID: 8339229
    [Abstract] [Full Text] [Related]

  • 27. Growth hormone-prolactin-thyrotropin-secreting pituitary adenoma in atypical McCune-Albright syndrome with functionally normal Gs alpha protein.
    Gessl A, Freissmuth M, Czech T, Matula C, Hainfellner JA, Buchfelder M, Vierhapper H.
    J Clin Endocrinol Metab; 1994 Oct 15; 79(4):1128-34. PubMed ID: 7962285
    [Abstract] [Full Text] [Related]

  • 28. G protein amino-terminal alpha i2/alpha s chimeras reveal amino acids important in regulating alpha s activity.
    Russell M, Johnson GL.
    Mol Pharmacol; 1993 Aug 15; 44(2):255-63. PubMed ID: 8394989
    [Abstract] [Full Text] [Related]

  • 29. Hydrolysis of GTP by the alpha-chain of Gs and other GTP binding proteins.
    Bourne HR, Landis CA, Masters SB.
    Proteins; 1989 Aug 15; 6(3):222-30. PubMed ID: 2516316
    [Abstract] [Full Text] [Related]

  • 30. Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas.
    Barlier A, Gunz G, Zamora AJ, Morange-Ramos I, Figarella-Branger D, Dufour H, Enjalbert A, Jaquet P.
    J Clin Endocrinol Metab; 1998 May 15; 83(5):1604-10. PubMed ID: 9589663
    [Abstract] [Full Text] [Related]

  • 31. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas.
    Vallar L, Spada A, Giannattasio G.
    Nature; 1998 May 15; 330(6148):566-8. PubMed ID: 2825031
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Recent advances in the molecular biology of growth-hormone secreting human pituitary tumours.
    Adams EF, Buchfelder M, Hüttner A, Moreth S, Fahlbusch R.
    Exp Clin Endocrinol; 1993 May 15; 101(1):12-6. PubMed ID: 8477819
    [Abstract] [Full Text] [Related]

  • 34. Pituitary adenomas: screening for G alpha q mutations.
    Oyesiku NM, Evans CO, Brown MR, Blevins LS, Tindall GT, Parks JS.
    J Clin Endocrinol Metab; 1997 Dec 15; 82(12):4184-8. PubMed ID: 9398737
    [Abstract] [Full Text] [Related]

  • 35. Activating point mutations of the gsp oncogene in human thyroid adenomas.
    O'Sullivan C, Barton CM, Staddon SL, Brown CL, Lemoine NR.
    Mol Carcinog; 1991 Dec 15; 4(5):345-9. PubMed ID: 1910478
    [Abstract] [Full Text] [Related]

  • 36. [Genetic changes in human pituitary adenomas].
    Spada A, Lania A.
    Minerva Endocrinol; 2003 Mar 15; 28(1):27-37. PubMed ID: 12621361
    [Abstract] [Full Text] [Related]

  • 37. Gonadotropin-releasing hormone initiates multiple signaling pathways in human GH-secreting adenomas.
    Lania A, Mantovani G, Ferrante E, Zavanone LM, Locatelli M, Corbetta S, Beck-Peccoz P, Spada A.
    J Endocrinol Invest; 2004 Apr 15; 27(4):328-33. PubMed ID: 15233551
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation.
    Xu T, Ye F, Wang B, Tian C, Wang S, Shu K, Guo D, Lei T.
    Neuro Endocrinol Lett; 2010 Apr 15; 31(1):147-54. PubMed ID: 20150876
    [Abstract] [Full Text] [Related]

  • 40. Genetic and structural analysis of G protein alpha subunit regulatory domains.
    Johnson GL, Dhanasekaran N, Gupta SK, Lowndes JM, Vaillancourt RR, Ruoho AE.
    J Cell Biochem; 1991 Oct 15; 47(2):136-46. PubMed ID: 1661737
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.